Phase I trial of ATRA-IV [AR 623] and Depakote [valproate semisodium] in patients with advanced solid tumor malignancies
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2009
At a glance
- Drugs AR 623 (Primary) ; Valproate semisodium (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 22 Oct 2005 New trial record.